TY  - JOUR
TI  - LAG-3 expression in tumor microenvironment of triple-negative breast cancer
AB  - Background/aim: This study aimed to evaluate the expression of lymphocyte activation gene-3 (LAG-3) and its relationship with programmed cell death ligand-1 (PD-L1) in triple-negative breast cancer (TNBC). Materials and methods: LAG-3 and PD-L1 was evaluated in tumor-infiltrating lymphocytes (TILs) using immunohistochemistry (IHC). The chi-square test was used to estimate the associations between LAG-3, PD-L1 and clinicopathological characteristics. Correlation between LAG-3 stromal TIL (sTIL), LAG-3 intraepitelial TIL (iTIL) and PD-L1 was assessed with using the Spearman’s correlation coefficient. Survival analysis was performed using the Kaplan-Meier method. Results: The percentages of LAG-3 sTIL+, LAG-3 iTIL+, PD-L1+ tumor cells and PD-L1+ inflammatory cells were 52%, 42%, 14% and 70%, respectively. A strong positive correlation between LAG-3 sTIL and LAG-3 iTIL (r = 0.874, p < 0.001) and a moderate positive correlation between LAG-3 sTIL and PD-L1 (r = 0.584, p < 0.001) were found. LAG-3 and PD-L1 status did not significantly affect overall survival (OS) (HR: 0.56 (95% CI: 0.15–2.11) (p = 0.397), HR: 2.70 (95% CI: 0.56–13.02) (p = 0.215), respectively). Conclusion: High levels of LAG-3 and PD-L1 expression were detected in patients with TNBC. Although their contribution to survival could not be determined, the high expression rates of PD-L1 and LAG-3 may help identify the subgroup of TNBC that would benefit from immunotherapy.
AU  - Akyurek, Nalan
AU  - tahtaci, gozde
AU  - GÜNEL, NAZAN
AU  - Sadioğlu, Aysu
AU  - Boz, Oğulcan
DO  - 10.55730/1300-0144.5567
PY  - 2023
JO  - Turkish Journal of Medical Sciences
VL  - 53
IS  - 1
SN  - 1300-0144
SP  - 142
EP  - 148
DB  - TRDizin
UR  - http://search/yayin/detay/1160102
ER  -